| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |